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Statistical hypothesis test of factor loading in
principal component analysis and its
application to metabolite set enrichment
analysis
Hiroyuki Yamamoto, Tamaki Fujimori, Hajime Sato, Gen Ishikawa, Kenjiro
Kami, and Yoshiaki Ohashi

Abstract

Principal component analysis (PCA) has been widely used to visualize highdimensional metabolomic data in a two- or three-dimensional subspace. In metabolomics,
some metabolites (e.g. top 10 metabolites) have been subjectively selected when
using factor loading in PCA, and biological inferences for these metabolites are
made. However, this approach is possible to lead biased biological inferences because these metabolites are not objectively selected by statistical criterion. We
proposed a statistical procedure to pick up metabolites by statistical hypothesis
test of factor loading in PCA and make biological inferences by metabolite set
enrichment analysis (MSEA) for these significant metabolites. This procedure
depends on the fact that the eigenvector in PCA for autoscaled data is proportional to the correlation coefficient between PC score and each metabolite levels.
We applied this approach for two metabolomic data of mice liver samples. 136
of 282 metabolites in first case study and 66 of 275 metabolites in second case
study were statistically significant. This result suggests that to set the previouslydetermined number of metabolites is not appropriate because the number of significant metabolites is different in each study when using factor loading in PCA.
Moreover, MSEA was performed for these significant metabolites and significant
metabolic pathways can be detected. These results are acceptable when compared
with previous biological knowledge. It is essential to select metabolites statistically for making unbiased biological inferences from metabolome data, when using factor loading in PCA. We proposed a statistical procedure to pick up metabolites by statistical hypothesis test of factor loading in PCA and make biological

inferences by MSEA for these significant metabolites. We developed an R package ”mseapca” to perform this approach. The “mseapca” package is publicity
available on CRAN website.

Background
Metabolomics is a science based on exhaustive-profiling of metabolites. In
metabolomics,
various
analytical
technologies
such
as
capillary
electrophoresis–mass spectrometry (CE–MS), liquid chromatography–mass
spectrometry (LC–MS), gas chromatography–mass spectrometry (GC–MS) and
nuclear magnetic resonance (NMR) etc. have been used. Statistical analysis for
these analytical data has been studied in chemometrics research area [1]. In
metabolomics, chemometrics approaches commercing with multivariate analysis
such as principal component analysis (PCA) have been mainly applied.
PCA [2] has been routinely used to visualize high-dimensional metabolomic data
in two- or three-dimensional subspace in metabolomics as well as a heat map in
transcriptmics. A scatter plot of PC score vectors (a score plot) can be used for
outlier detection or discovering biologically interpretable patterns. Typically,
upon finding a specific PC score is related to a phenotype of interest [3, 4], such
as time course or group information, the corresponding factor loading has been
evaluated to discover meaningful metabolites for making biological inferences.
In many metabolomics research articles [5, 6, 7], an eigenvector in PCA (eq. 1)
has been used as factor loading. For making biological inferences, some
metabolites (e.g. top 10 metabolites) has been subjectively selected by using the
eigenvector. However, this approach has some problems. For example, many
metabolites varies with phenotype in a study and only a few metabolites in
another study. An existing approach using the eigenvector equals to set the same
number of metabolites for making biological inferences among these different
studies. As a result, biological interpretation might be performed by using not
significant metabolites varied with phenotype irrelevantly. Additionally, the value
of eigenvector itself does not have statistical sense because it is nothing but
normalized that the sum of squares is 1 just for computational reason.
The eigenvectors in PCA for autoscaled data [8] are proportional to correlation
coefficient between PC scores and variables. This fact is well-known in
multivariate analysis literature [9] but appears not to be appreciated in
metabolomics. In the present study, factor loading was defined as correlation
coefficient between PC scores and variables. This definition can be used to
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perform statistical hypothesis testing and can select significant metabolites
objectively by statistical criteria.
Significant metabolites are selected in some way and afterward biological
inferences are made for these metabolites by biologists. They often make
biological inferences with respect to a biological functional unit such as metabolic
pathway (e.g. “glycolysis is notably activated” or “an amino acid metabolism is
significantly suppressed”). In gene expression analysis, gene set enrichment
analysis (GSEA) has been applied to find significant gene sets by using gene
ontology (GO) terms. In metabolomics, metabolite set enrichment analysis
(MSEA) [10] can find significant metabolic pathway. MSEA has been computed
by some approaches such as over representation analysis (ORA) [11],
Subramanian’s GSEA [12] and global test [13]. MSEA is convenience to make
biological inferences from metabolomic data, but this approach has not been
applied for metabolites selected by factor loading in PCA.
In the present study, we performed statistical hypothesis test of factor loading
in PCA for two metabolomic data sets of mice liver samples as case studies. This
approach can select significant metabolites when using factor loading in PCA, and
MSEA by ORA approach can be applied for these significant metabolites. We
developed the R package ‘mseapca’ to work sequence from statistical hypothesis
test of factor loading in PCA to MSEA.
Theory
Principal Component Analysis (PCA)
Consider a mean-centered data matrix X that has samples in each row and
variables in each column. A score vector is related to the data matrix by t = Xw
where w is a vector of weights. PCA is formulated as the optimization problem of
maximizing the variance of the score vector t:
max var(t )
(1-1)
subject to w' w = 1
and the weight vector w is often used for factor loading. After a transformation, eq.
(1-1) can be rewritten as the eigenvalue problem
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1
X' Xw = λw
n −1
.

(1-2)

An eigenvector w and eigenvalue λ of eq. (1-2) can be computed by using
numerical computation libraries for singular value decomposition. An eigenvalue
λ corresponds to the variance of the PC score vector formed using the associated
eigenvector as the weight vector.
A coefficient of the correlation between the PC score and the p-th variable can
be defined as
corr ( t , x p ) =

t' x p / n − 1

(1-3)

var( t ) var( x p )

where t' is the transpose of t. Introducing c as the column vector in which the p-th
element is 1 and the others are 0, so that xp = Xc, we have

corr(t, xp ) =

w' X' Xc / n − 1
var(t) var(xp )

(1-4)
.

Transposing eq. (1-2) gives w' X' X / n −1 = λw' which can be substituted in eq.
(1-4), giving

corr(t, xp ) =

λw' c
var(t) var(x p )

(1-5)
.

Then the variance of the score vector can be replaced by λ and the standard
deviation of xp is replaced by σp. Finally, the correlation between PC score and
variables can be written as

corr(t, xp ) =

λw' c
var(t ) var(xp )

=

λwp
λσ p

=

λ wp
σp

(1-6)
.

With data scaled to unit variance (autoscaling), the weight wp is proportional to
the correlation coefficient between the PC score and variable xp because σp = 1 in
eq. (1-6). Thus, the factor loading can be defined as the correlation coefficient in
eq. (1.6). On the basis of this definition, we can perform a statistical test for factor
loading in PCA, using the well-known fact that, for a correlation coefficient r, the
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statistic
t=

r n−2
1− r

2

(1-7)

has a t-distribution with (n-2) degrees of freedom. Then, we can select variables
that have a statistically significant correlation with the PC score and make
biological inferences using these variables.
Materials and Methods
Sample preparation, metabolome analysis and data processing
BKS.Cg-m+/m+/Jcl (normal mice), 12-h fasting normal mice,
BKS.C-+Leprdb/+Leprdb/Jcl (db/db mice) and db/db mice orally administered
pioglitazone for 10 days were used. The mice were seven-week-old males with
unlimited access to food and water except for those on the 12-h fasting. The
concentration of administered pioglitazone was 100 mg/10 mL/kg. The
pioglitazone was purchased from Takeda Pharmaceutical Co. ltd, and purified by
NARD Institute Ltd. After sampling, the livers were excised and stored at –80 ℃.
From purchase and breeding of the mice to collection of liver samples, all
experiments were performed at the Kitayama Labs Co. Ltd. The sample
preparation procedure to extract metabolites was that described by Ooga et al
[14].
The metabolite extracts were measured by capillary electrophoresis
time-of-flight mass spectrometry (CE-TOFMS). CE-TOFMS was carried out
using Agilent Capillary Electrophoresis Systems equipped with an Agilent 6210
time-of-flight mass spectrometer, an Agilent 1100 isocratic HPLC pump, an
Agilent G1603A CE-MS adapter kit and an Agilent G1607A CE-ESI-MS sprayer
kit (Agilent Technologies, Waldbronn, Germany). The system was controlled by
G2201AA ChemStation Software version B.03.01 for CE (Agilent Technologies,
Waldbronn, Germany). Modified analytical methods for the measurement of
cationic [15] and anionic metabolites [16] were used. Measurement data were
processed by peak processing software [17]. Signal peaks corresponding to
isotopomers, adduct ions and other product ions of known metabolites were
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excluded. Then all signal peaks potentially corresponding to authentic compounds
were extracted, and their migration time (MT) was normalized using those of the
internal standards (methionine sulfone and CSA for cations and anions,
respectively). Thereafter, the alignment of peaks was performed according to the
m/z values and normalized MT values. Finally, peak areas are normalized against
those of the internal standards. The resultant relative area values were further
normalized by the sample weight. Annotation tables were produced from
CE-TOFMS measurements of standard compounds, and were aligned with
datasets according to similar m/z values and normalized MT values.
Statistical Analysis
In the present study, all computation were performed by R [18] and “mseapca”
[19] package. A missing value was imputed to 0 for a computation of PCA. A
metabolite set list was created by referring to KEGG [20], and partial
modification was performed by manual curation. The xml file of metabolite set
list used in this study is included in “mseapca” package.
Software
An R package “mseapca” [19] consists of three major features. The first
one is to create a list of metabolic pathway. A “csv2list“ function converts your
own csv file in which first column is name of metabolic pathway and second
column is metabolite IDs to list format in R. A “pathway_class” function converts
KEGG’s tar.gz files (e.g. hsa.tar.gz in Homo sapience) to list format of metabolic
pathway. The KEGG’s tar.gz files can be downloaded from KEGG FTP according
to your own license. A “list2xml” function converts list format of metabolic
pathway to xml format. This xml format can be saved as xml file by
using ”saveXML” function in “XML” package. A ”read_pathway” function can
read the created xml file and convert to list of metabolic pathway for a
computation of MSEA.
The second one is a “pca_scaled” function to perform PCA. In this
function, data matrix is automatically scaled to zero mean and unit variance
(autoscaling) for each metabolites. PC scores, factor loadings and p-value and
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q-value by Benjamini and Hochberg [21] as the results of statistical hypothesis
test of factor loading are returned. In this function, factor loading is defined as a
correlation coefficient between PC score and each metabolite levels.
The third one is to perform MSEA. A “msea_ora” function can perform
MSEA by over representation analysis (ORA) [11]. In this function, statistical
hypothesis test of cross tabulation is performed by one-sided Fisher’s exact test. A
“msea_sub” function performs MSEA implemented in the same fashion as GSEA
by Subramanian et al. In this function, a permutation procedure is performed for a
metabolite set rather than class label. This procedure corresponds to “gene set” of
permutation type in GSEA-P software [22]. A leading-edge subset analysis is also
undertaken following the GSEA procedure [21].
An R package “mseapca” can be freely available from CRAN web site
[19]. For details, see the reference manual in CRAN web site of "mseapca" [19]
for more information.
4. Results
4.1. Case study 1: a comparative study of control and 12-h fasting mice
We describe the utilization of statistical hypothesis test of factor loading in
PCA by using metabolome data in two studies. First case study is a comparative
study of normal and 12 hour fasting mouse. 5 liver samples each for control and
12 hour fasting mice were used for metabolome analysis. As a result, 282
metabolites were identified.
PCA was performed for this metabolome data preprocessed by autoscaling.
The score plot of PCA (Fig. 1 (A)) showed that the PC1 score of control and
fasting mice were negative and positive, respectively. This result suggests that the
PC1 score was positively related to fasting effect. In this case, metabolites which
have large positive factor loading in PC1 tended to increase and negative factor
loading tended to decreased with 12 hour fasting.
Statistical hypothesis test for factor loading in PC1 was performed, and
136 metabolites were statistically significant under p<0.05 (Supplementary
Table1). MSEA by ORA for factor loading was performed for positive and
negatively significant metabolites independently (Table1). The purine metabolism
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was significantly activated in 12 hour fasting mice under p<0.05. Glycolysis was
significantly suppressed under q<0.05 and pentose phospate pathway, TCA cycle,
cystein metabolism and polyamine metabolism were significantly suprressed in 12
hour fasting under p<0.05. MSEA by Subramanian et al. was also performed as a
reference (Table1). The histidine metabolism and purine metabolism having
negative normalized enrichment score (NES) were significantly activated in 12
hour fasting mice under p<0.05. Glycolysis having positive NES was significantly
suppressed under q<0.05 and pentose phospate pathway, TCA cycle and
polyamine metabolism were significantly suppressed in 12 hour fasting under
p<0.05. These results suggest that the results of these two MSEA approaches are
largely consistence.
The results of MSEA for factor loading in PC1 suggested that the process
of energy metabolism, such as glycolysis and the TCA cycle, were decreased by
12 hour fasting. The suppression of these metabolic pathway suggests that
glycogen is drained and glucose supplementation is restricted in mouse liver
under the condition of fasting 12 hour. And, body weight was 22.20±0.84
(mean±SD) in normal mouse and 20.0±0.71 in 12 hour fasting mouse, and
statistically significant decreased (p=0.0021) during 12 hour fasting by Welch’s
t-test. This result shows that the suppression of energy metabolism might result in
a decrease of body weight.
4.2. Case study 2: a comparative study between diabetes model mice without and
with administered pioglitazone
The db/db mouse is a model of obesity, diabetes and dyslipidemia in which
leptin receptor activity is deficient because the mice are homozygous for a point
mutation in the leptin receptor gene [23]. Pioglitazone reduces insulin resistance
in the liver and decreases glucose level in the blood [24, 25]. Hence, it is used for
the treatment of diabetes.
We compared the metabolome data of mouse liver samples from db/db mice
with and without pioglitazone in order to examine the effect of administering
pioglitazone to db/db mice. 5 liver samples each for db/db mice and db/db with
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administering pioglitazone were used for metabolome analysis. As a result, 275
metabolites were identified.
We performed PCA on data preprocessed by autoscaling in a comparative
study of db/db mice with and without administered pioglitazone. The score plot is
shown in Fig. 5. A perfect separation between groups could be achieved on the
first PC axis (Fig. 3), and thus we focused on this axis. The PC1 score of the
db/db mice with and without administered pioglitazone showed positive and
negative value, respectively, suggesting that PC1 score is positively related to the
effect of the administration of pioglitazone.
Statistical hypothesis test for factor loading in PC1 was performed, and 66
metabolites were statistically significant under p<0.05. MSEA for factor loading
was performed as well as the previous section (Table2). In both MSEA by ORA
and Subramanian’s approach, glycolysis was only statistically significant
activated by administered pioglitazone under p<0.05. Pioglitazone is a
peroxisome proliferator-activated receptor (PPAR) activating agent. Lee et al.
[26] suggested that PPARδ ameliorated hyperglycemia by increasing glucose flux
through the regulation of gene expression. And administering pioglitazone was
known to reduce the glucose level in blood [24, 25].
In the present study, glucose blood level was 369.6±64.8 (mean±SD) in db/db
mouse and 332.8±131.9 in db/db mice with administered pioglitazone. The
change of glucose blood level was not significantly decreased (p=0.596) by
administered pioglitazone by Welch’s t-test. This result suggests that metabolome
analysis could detect the subtle change caused by administering pioglitazone in
glycolysis pathway.
Discussion
Metabolite selection by statistical hypothesis test of factor loading in PCA
has some advantages. This approach was applied for metabolome data in two case
studies of mouse liver samples. 136 of 282 metabolites were significantly
correlated with PC1 score associated with groups in first case study and 66 of 275
metabolites in second study. The number of significant metabolites is twice larger
in first case study than in second case study. This result suggests that to set the
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previously-determined number of metabolites (e.g. top 10 metabolites) is not
appropriate because the number of significant metabolites is different in each
studies. Additionally, we note the relationship between contribution ratio and the
number of significant metabolites for factor loading in PCA. The ratio of the
number of significant metabolites to all detected metabolites is 0.482 (=136/282)
in first case study and 0.24 (=66/275) in second case study. The contribution ratio
in PC1 is 40.5% in first case study and 24.2% in second case study. This result
suggests that an implicit relationship between contribution ratio and the number of
significant metabolites under same sample size.
In both two case studies, we focused on PC1 (Fig.1 and Fig.2) which
shows difference between groups. Then, we compared this approach with
ordinary statistical hypothesis test such as t-test. 122 metabolites were significant
in first case study and 56 metabolites were significant in second case study by
Welch’s t-test. As compared with metabolites picked up by statistical test of factor
loading, 112 metabolites and 47 metabolites shared in each study. The fact that
most significant metabolites shared between two approaches suggests that
statistical test of factor loading in PCA can be readily used to pick up metabolites
as a special case of two-sample test when a difference between groups appears in
PC score. On the other hand, in metabolomics, complex studies such as a
fermentation process by microorganism [27] having various time points or groups
and drug administration having various concentration in various condition [28].
Statistical test for factor loading in PCA can be widely used not only two-sample
study but also various studies when PC score associated with phenotype can be
found.
MSEA was performed for significant metabolites and acceptable
biological inferences were given in two case studies. In conventional approach,
previously-determined number of metabolite (e.g. 10 metabolites) has been
subjectively selected for making biological inferences. According to this approach,
MSEA was performed for the top 10 metabolites having large negative factor
loading in first case study. No significant metabolic pathway was detected under
p<0.05 (data not shown). In this case, only 10 metabolites were too small for
making acceptable biological inferences. Even if significant metabolic pathways
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were detected by MSEA for not significant metabolites, it is doubtful whether
these significant metabolic pathways are meaningful statistically and biologically.
To make unbiased biological inferences by using statistical analysis, significant
metabolites should be selected by using statistical test of factor loading when
using in PCA.
In the present study, two MSEA approaches of ORA and Subramanian’s
approach were performed. As a way of utilizing factor loading for GSEA, Rudolf
S. N. Fehrmann et al. [29] named the PC score associated with phenotype as
transcriptional system regulators (TSR) score, and factor loading corresponding to
TSR score was used for GSEA by Subramanian’s approach. This directly uses the
factor loading but does not use the result of statistical hypothesis test of factor
loading. As far as we know, an approach combining GSEA or MSEA with the
result of statistical hypothesis test of factor loading in PCA has not been reported.
The result of both MSEA of ORA and Subramanian’s approach has almost
same results in two case studies. In a comparison of computational time between
two MSEA approaches, it cost 441.43 seconds by Subramanian’s approach and
0.83 seconds by ORA in first case study. This result showed that MSEA of ORA
has an advantage about computational cost. Conventionally, PCA and MSEA can
be computed in different step or software independently. There has not been
software which can compute as sequence from PCA and statistical hypothesis test
of factor loading to MSEA. Therefore, we developed an R package “mseapca” to
work sequence from statistical hypothesis test of factor loading in PCA to MSEA.
Conclusion
In metabolomics, targeted metabolites for making biological inferences
were subjectively selected when using factor loading in PCA. We proposed a
statistical procedure to pick up metabolites by statistical hypothesis test of factor
loading in PCA, and these significant metabolites was used to find significant
metabolic pathway by MSEA. We applied this approach to two metabolomic data
of mouse liver samples, and acceptable results were given when compared with
previous biological knowledge. We developed an R package “mseapca” to
examine our approach readily. There are many users of PCA in metabolomics.
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Our approach can improve an existing use of PCA and is expected to be widely
applied.
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Fig. 1. Result of PCA in a comparative study of normal and 12-h fasting mice. (A)
Score plot of PC1 and PC2. Symbols: (○) control mouse; (●) 12-h fasting mouse.
(B) Factor loading plot in PC1. Metabolites are sorted in ascending order of the
value of factor loading. The dotted line shows the significant level under p<0.05.
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Fig. 2. Result of PCA in a comparative study of diabetes model mice with and
without administered pioglitazone. (A) Score plot of PC1 and PC2. Symbols: (○)
diabetes model mouse (db/db mouse) without administered pioglitazone; (●)
db/db mouse with administered pioglitazone. (B) Factor loading plot in PC1.
Metabolites are sorted in ascending order of the value of factor loading. The
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dotted line shows the significant level under p<0.05. The dotted line shows
significant level under p<0.05.

Hosted by The Berkeley Electronic Press

positive correlation with PC1
p -value
q -value
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
0.8254
1.0000
0.8567
1.0000
1.0000
1.0000
0.7434
1.0000
0.6489
1.0000
0.6178
1.0000
1.0000
1.0000
0.5434
1.0000
0.8567
1.0000
1.0000
1.0000
1.0000
1.0000
0.7413
1.0000
1.0000
1.0000
0.2111
1.0000
1.0000
1.0000
0.7874
1.0000
0.0285
*
0.7411
0.9649
1.0000
0.3473
1.0000
1.0000
1.0000
0.5361
1.0000
0.3473
1.0000

negative correlation with PC1
p -value
q -value
0.0001
*
0.0036
**
0.0308
*
0.2000
0.0040
*
0.0519
0.4901
0.9801
0.2878
0.8313
0.8681
1.0000
0.7735
1.0000
0.0720
0.2445
0.0412
*
0.2142
0.8444
1.0000
0.4901
0.9801
1.0000
1.0000
0.0507
0.2197
0.6001
1.0000
0.0308
*
0.2000
0.9269
1.0000
0.0752
0.2445
0.8616
1.0000
0.3721
0.9675
0.4705
0.9801
0.9983
1.0000
0.9860
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
0.5357
0.9949

Table 1. Results of MSEA by ORA and Subramanian's approach in a comparative study of normal and 12-h fasting mice.
ORA

Glycolysis
Pentose phosphate pathway
TCA cycle
Glutamic acid and glutamine metabolism
Alanine, aspartic acid and asparagine metabolism
Lysine metabolism
Valine, leucine and isoleucine metabolism
Glycine, serine and threonine metabolism
Cysteine metabolism
Methionine metabolism
Shikimic acid metabolism
Histidine metabolism
Urea cycle
Proline metabolism
Polyamine metabolism
Tryptophan metabolism
Tyrosine metabolism
beta-alanine metabolism
Taurine metabolism
Creatine metabolism
Purine metabolism
Pyrimidine metabolism
Ribonucleotide metabolism
Deoxyribonucleotide
Conjugated bile acid
Nicotinic acid metaboilsm
*p <0.05, **q<0.05,

Subramanian's approach
positive correlation with PC1
NES
p -value
q -value
-2.0048
0.0000
*
0.0074
-1.6040
0.0283
*
0.1781
-1.6208
0.0165
*
0.2433
-1.0936
0.3497
0.5193
-1.1897
0.2625
0.4379
-0.8172
0.7078
0.8274
-0.9392
0.5636
0.7311
-1.2557
0.1803
0.3704
-1.3259
0.1611
0.3371
0.8697
0.6147
0.7197
-1.2676
0.1745
0.3901
1.8978
0.0080
*
0.0520
-1.3352
0.1524
0.3705
-1.1524
0.3041
0.4619
-1.5785
0.0309
*
0.1581
-0.7141
0.8260
0.8764
-1.3601
0.1176
0.3820
0.9218
0.5531
0.7578
-1.4114
0.1010
0.3535
-0.8041
0.7093
0.7984
1.6391
0.0220
*
0.1290
0.7965
0.7355
0.7258
1.1184
0.2800
0.6998
-0.6743
0.9776
0.8725
1.0384
0.3671
0.6834
-0.8360
0.6536
0.8510

**
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positive correlation with PC1
p-value
q-value
0.0090
*
0.2250
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
0.5531
1.0000
1.0000
1.0000
0.3294
1.0000
0.1405
0.7024
0.7041
1.0000
1.0000
1.0000
0.3294
1.0000
1.0000
1.0000
1.0000
1.0000
0.5051
1.0000
0.1344
0.7024
0.1018
0.7024
0.4521
1.0000
0.3893
1.0000
0.0577
0.7024
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
0.3161
1.0000

negative correlation with PC1
p-value
q-value
0.7982
1.0000
1.0000
1.0000
1.0000
1.0000
0.5471
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
0.8617
1.0000
0.2461
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
0.2701
1.0000
1.0000
1.0000
1.0000
1.0000
0.6321
1.0000
0.4410
1.0000
0.7206
1.0000
0.2583
1.0000
0.9252
1.0000
0.2461
1.0000
0.4687
1.0000
0.5431
1.0000

Table2. Results of MSEA by ORA and Subramanian's approach in a comparative study of diabetes model mice with and without administered pioglitazone.
ORA
Subramanian's approach
positive correlation with PC1
NES
p-value
q-value
1.6888
0.0198
*
0.3485
1.3813
0.1378
0.9520
-1.4237
0.0916
0.8261
-1.2740
0.2062
0.4203
0.7161
0.8049
1.0000
-0.6892
0.8152
0.9603
0.8275
0.6150
0.9834
1.1241
0.2699
0.9823
-0.9727
0.4840
0.8845
1.0388
0.4167
0.9189
1.1493
0.3098
1.0000
0.7463
0.7770
1.0000
0.6208
0.9293
0.9238
0.6493
0.8869
1.0000
1.0695
0.3818
0.9813
1.2380
0.2247
1.0000
0.9319
0.5367
0.8548
0.6450
0.8899
0.9596
0.9952
0.4654
0.8048
-0.7887
0.7230
0.9414
-1.3788
0.0947
0.5203
-0.7940
0.7196
1.0000
-1.3605
0.1215
0.3792
-0.5472
0.9689
0.9709
0.9991
0.4427
0.8973

Glycolysis
Pentose phosphate pathway
TCA cycle
Glutamic acid and glutamine metabolism
Alanine, aspartic acid and asparagine metabolism
Lysine metabolism
Valine, leucine and isoleucine metabolism
Glycine, serine and threonine metabolism
Cysteine metabolism
Methionine metabolism
Shikimic acid metabolism
Histidine metabolism
Urea cycle
Proline metabolism
Polyamine metabolism
Tryptophan metabolism
Tyrosine metabolism
beta-alanine metabolism
Taurine metabolism
Creatine metabolism
Purine metabolism
Pyrimidine metabolism
Ribonucleotide metabolism
Conjugated bile acid
Nicotinic acid metaboilsm
*p <0.05, **q<0.05,
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